drugset / Trial / NCT00071448
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients.
Timeline
- Start
- 2002-06
- Primary completion
- 2004-06
- Completion
- 2004-06
Publications
- Results Arslanian S, Foster C, Wright N, Stender S, Hu P, Hale P, Hale D. Comparison of Insulin Aspart, Regular Insulin, and Insulin Lispro in Basal Bolus Therapy with NPH To Treat Pediatric Patients with Type 1 Diabetes Mellitus. Diabetes 2005; 54 ((suppl 1)): A517 [Abstract 2150-PO]
- Results Arslanian S, Foster C, Wright NM, Stender S, Hale P, Hale D. Insulin apart compared to regular insulin and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus. EASD 2005 2005; 48(Suppl. 1): A327
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | — |
| Subject | Insulin Lispro | Protein / enzyme biologic | — | — |
| Subject | insulin aspart | Protein / enzyme biologic | — | — |